Enceladus Pharmaceuticals Overview

  • Founded
  • 2005
  • Status
  • Out of Business
  • Employees
  • 2
  • Latest Deal Type
  • Out of Business

Enceladus Pharmaceuticals General Information


Developer of drugs intended to aim at finding innovative combinations of existing drugs and drug carrier systems. The company's drugs contain an anti-inflammatory corticosteroid that selectively targets the drug to the actual sites of pathology in inflammatory disorders, enabling users to get liposomal formulations of corticosteroids to treat inflammatory, autoimmune diseases and cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • St Annastraat 38a
  • 1411 PH Naarden
  • Netherlands
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Enceladus Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 22-Jun-2021 Completed Out of Business
2. Early Stage VC 09-Jul-2007 Completed Startup
1. Early Stage VC 01-Jan-2005 Completed Startup
To view Enceladus Pharmaceuticals’s complete valuation and funding history, request access »

Enceladus Pharmaceuticals Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of drugs intended to aim at finding innovative combinations of existing drugs and drug carrier systems. The co
Drug Discovery
Naarden, Netherlands
2 As of 2020
00000000 00

00000 00

am, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
0000 000000000
Seattle, WA
00 As of 0000
0000000000 0000


aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cil
0000 000000000
Utrecht, Netherlands
00 As of 0000
00.00 0000-00-00
000000&0 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enceladus Pharmaceuticals Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lumen Bioscience Venture Capital-Backed Seattle, WA 00 0000 0000000000 0000
000000000 00000000 Formerly VC-backed Utrecht, Netherlands 00 00.00 000000&0 00.00
00000000 000000000 Private Equity-Backed Stockholm, Sweden 00 000.00 000000 - 000 000.00
00000000 000000000 Private Equity-Backed Noáin, Spain 000 00.000 000000000000 00.000
0000000 0000000000 Formerly VC-backed Cambridge, MA 000 000.00 000000000 000.00
You’re viewing 5 of 9 competitors. Get the full list »

Enceladus Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial